Anti-Human CD38 Recombinant Antibody(Daratumumab)

Product Information

Catalog Number	YR1199
Product Name	Anti-Human CD38 Recombinant Antibody(Daratumumab)
Molecular Name	Daratumumab
Alias	Anti-CD38 Recombinant Antibody, Research Grade Daratumumab
CAS Number	945721-28-8
Molecular Weight	148 kDa
Target	CD38[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	WB, IP, IF, FuncS, FCM, Neut, ELISA
Buffer	PBS, pH7.5
Background	Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price